Multiple Myeloma Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2019 – 2028

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1      Primary Research

1.3.2      Secondary Research

1.3.3      In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Multiple Myeloma Market Year-on-Year Growth, 2020 - 2028 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1      Drivers

3.5.1.1      Impact Analysis

3.5.2      Restraints

3.5.2.1      Impact Analysis

3.5.3      Opportunities

Chapter 4        Global Multiple Myeloma Market by Therapy: Market Size and Forecast, 2019 – 2028

4.1    Overview

4.2  Targeted Therapy

4.2.1    Current Trend and Analysis

4.2.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

4.2.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.3  Biologic Therapy

4.3.1    Current Trend and Analysis

4.3.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

4.3.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.4  Chemotherapy

4.4.1      Current Trend and Analysis

4.4.2      Market Size and Forecast, 2019 - 2028 ($ Billion)

4.4.3      Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.5  Others

4.5.1      Current Trend and Analysis

4.5.2      Market Size and Forecast, 2019 - 2028 ($ Billion)

4.5.3      Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 5        Global Multiple Myeloma Market by Drug Type: Market Size and Forecast, 2019 – 2028

5.1  Overview

5.2  Immunomodulatory Drugs

5.2.1    Current Trend and Analysis

5.2.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.3  Proteasome Inhibitors

5.3.1      Current Trend and Analysis

5.3.2      Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.3      Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.4  Histone Deacetylase Inhibitors

5.4.1    Current Trend and Analysis

5.4.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

5.4.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.5  Monoclonal Antibody Drugs

5.5.1      Current Trend and Analysis

5.5.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

5.5.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.6  Steroids

5.6.1      Current Trend and Analysis

5.6.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

5.6.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.7  Others

5.7.1      Current Trend and Analysis

5.7.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

5.7.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 6        Global Multiple Myeloma Market by Distribution Channel: Market Size and Forecast, 2019 - 2028

6.1  Overview

6.2  Hospitals Pharmacies

6.2.1    Current Trend and Analysis

6.2.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

6.3  Retail Pharmacies & Drug Stores

6.3.1      Current Trend and Analysis

6.3.2      Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.3      Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

6.4  Online Pharmacies

6.4.1      Current Trend and Analysis

6.4.2      Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.3      Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 7        Global Multiple Myeloma Market by Geography: Market Size and Forecast, 2019 – 2028

7.1  Overview

7.1.1    Global Multiple Myeloma Market Year-on-Year Growth, by region 2020 – 2028 (%)

7.2  North America

7.2.1    Current Trend and Analysis

7.2.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.3    U.S.

7.2.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.3.2        By Therapy

7.2.3.3        By Drug Type

7.2.3.4        By Distribution Channel

7.2.4    Canada

7.2.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.4.2        By Therapy

7.2.4.3        By Drug Type

7.2.4.4        By Distribution Channel

7.2.5    Mexico

7.2.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.5.2        By Therapy

7.2.5.3        By Drug Type

7.2.5.4        By Distribution Channel

7.2.6    Rest of North America

7.2.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.6.2        By Therapy

7.2.6.3        By Drug Type

7.2.6.4        By Distribution Channel

7.3    Europe

7.3.1    Current Trend and Analysis

7.3.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.3    UK

7.3.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.3.2        By Therapy

7.3.3.3        By Drug Type

7.3.3.4        By Distribution Channel

7.3.4    Russia

7.3.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.4.2        By Therapy

7.3.4.3        By Drug Type

7.3.4.4        By Distribution Channel

7.3.5    France

7.3.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.5.2        By Therapy

7.3.5.3        By Drug Type

7.3.5.4        By Distribution Channel

7.3.6    Italy

7.3.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.6.2        By Therapy

7.3.6.3        By Drug Type

7.3.6.4        By Distribution Channel

7.3.7    Germany

7.3.7.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.7.2        By Therapy

7.3.7.3        By Drug Type

7.3.7.4        By Distribution Channel

7.3.8    Rest of Europe

7.3.8.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.8.2        By Therapy

7.3.8.3        By Drug Type

7.3.8.4        By Distribution Channel

7.4    Asia-Pacific

7.4.1    Current Trend and Analysis

7.4.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.3    China

7.4.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.3.2        By Therapy

7.4.3.3        By Drug Type

7.4.3.4        By Distribution Channel

7.4.4    India

7.4.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.4.2        By Therapy

7.4.4.3        By Drug Type

7.4.4.4        By Distribution Channel

7.4.5    Japan

7.4.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.5.2        By Therapy

7.4.5.3        By Drug Type

7.4.5.4        By Distribution Channel

7.4.6    Rest of Asia-Pacific

7.4.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.6.2        By Therapy

7.4.6.3        By Drug Type

7.4.6.4        By Distribution Channel

7.5    RoW

7.5.1    Current Trend and Analysis

7.5.2    Market Size and Forecast

7.5.3    South America

7.5.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.5.3.2        By Therapy

7.5.3.3        By Drug Type

7.5.3.4        By Distribution Channel

7.5.4    Middle East

7.5.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.5.4.2        By Therapy

7.5.4.3        By Drug Type

7.5.4.4        By Distribution Channel

7.5.5    Africa

7.5.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.5.5.2        By Therapy

7.5.5.3        By Drug Type

7.5.5.4        By Distribution Channel

Chapter 8        Company Profiles

8.1  Basware Corporation

8.1.1      Company Overview

8.1.2      Product Portfolio

8.1.3      Business Strategies

8.1.4      Financials

8.1.5      Recent Developments

8.2  GlaxoSmithKline

8.2.1      Company Overview

8.2.2      Product Portfolio

8.2.3      Business Strategies

8.2.4      Financials

8.2.5      Recent Developments

8.3  Kyprolis

8.3.1      Company Overview

8.3.2      Product Portfolio

8.3.3      Business Strategies

8.3.4      Financials

8.3.5      Recent Developments

8.4  Bristol-Myers Squibb Company

8.4.1      Company Overview

8.4.2      Product Portfolio

8.4.3      Business Strategies

8.4.4      Financials

8.4.5      Recent Developments

8.5  Oncopeptides AB

8.5.1      Company Overview

8.5.2      Product Portfolio

8.5.3      Business Strategies

8.5.4      Financials

8.5.5      Recent Developments

8.6  Secura Bio

8.6.1      Company Overview

8.6.2      Product Portfolio

8.6.3      Business Strategies

8.6.4      Financials

8.6.5      Recent Developments

8.7  Takeda Pharmaceutical Company Limited

8.7.1      Company Overview

8.7.2      Product Portfolio

8.7.3      Business Strategies

8.7.4      Financials

8.7.5      Recent Developments

8.8  Sanofi

8.8.1      Company Overview

8.8.2      Product Portfolio

8.8.3      Business Strategies

8.8.4      Financials

8.8.5      Recent Developments

8.9  Karyopharm Therapeutics

8.9.1      Company Overview

8.9.2      Product Portfolio

8.9.3      Business Strategies

8.9.4      Financials

8.9.5      Recent Developments

8.10       Janssen Biotech

8.10.1   Company Overview

8.10.2   Product Portfolio

8.10.3   Business Strategies

8.10.4   Financials

8.10.5   Recent Developments

8.11       Celgene Corporation

8.11.1   Company Overview

8.11.2   Product Portfolio

8.11.3   Business Strategies

8.11.4   Financials

8.11.5   Recent Developments

8.12       RAPA Therapeutics

8.12.1   Company Overview

8.12.2   Product Portfolio

8.12.3   Business Strategies

8.12.4   Financials

8.12.5   Recent Developments

8.13       Pfizer

8.13.1   Company Overview

8.13.2   Product Portfolio

8.13.3   Business Strategies

8.13.4   Financials

8.13.5   Recent Developments

8.14       Cellectar Biosciences

8.14.1   Company Overview

8.14.2   Product Portfolio

8.14.3   Business Strategies

8.14.4   Back to top